Enhancing Quality Measurement With Clinical Information: A Use Case of Body Mass Index Change Among Children Taking Second Generation Antipsychotics.

"The authors have no conflicts of interest to disclose."

"Financial statement : This study was supported by grant U18HS025298 from the Agency for Healthcare Research and Quality. Research reported in this publication also was supported in part by the University of Florida Clinical and Translational Science Institute, which is supported in part by the NIH National Center for Advancing Translational Sciences under award number UL1TR001427. Dr Sarah Scholle was supported by grant U18HS025296 from the Agency for Healthcare Research and Quality. At the time the paper was written, Dr Michelle Cardel was supported by the National Institute of Health (NIH) National Heart, Lung, and Blood Institute (K01HL141535). Dr Dominick Lemas was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK115632), and Dr Keith Muller was supported by NIH National Institute of General Medical Sciences grant R01GM121081. The content is solely the responsibility of the authors and does not necessarily represent the official views of the University of Florida’s Clinical and Translational Science Institute or the National Institutes of Health."